Caroline Gravel Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB Health canada Biography Publications Institution JoVE Articles Caroline Gravel has not added a biography. If you are Caroline Gravel and would like to personalize this page please email our Author Liaison for assistance. Publications L'effetto Dell'interferone-α Sull'espressione Del Citocromo P450 3A4 in Cellule Di Epatoma Umano Toxicology and Applied Pharmacology. Jun, 2011 | Pubmed ID: 21466820 Optimization and Qualification of a Quantitative Reversed-phase HPLC Method for Hemagglutinin in Influenza Preparations and Its Comparative Evaluation with Biochemical Assays Vaccine. Apr, 2011 | Pubmed ID: 21397719 Qualitativa E Analisi Quantitative Di Praticamente Tutti I Sottotipi Di Neuraminidases Virale Dell'influenza A E B Usando Gli Anticorpi Targeting Per Le Sequenze Conservate Universalmente Vaccine. Aug, 2010 | Pubmed ID: 20621113 Paracetamolo Modula La Risposta Trascrizionale Di Interferone-beta Ricombinante PloS One. 2010 | Pubmed ID: 20544007 Analisi quantitativa di tutti influenza di tipo A Hemagglutinins e neuraminidasi virale utilizzando anticorpi Universale di saggi semplice Slot Blot Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection
Analisi quantitativa di tutti influenza di tipo A Hemagglutinins e neuraminidasi virale utilizzando anticorpi Universale di saggi semplice Slot Blot Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection
